Speech-Language Pathologists in Duncan, SC Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Treasured Therapy Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 179 Fair Orchard Way, Duncan, SC 29334 Phone: 704-989-6280

Mrs. Jennifer Marie Echenagucia, MA CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 165 Jonathan Ct, Duncan, SC 29334 Phone: 864-907-3383

Gabrielle Eberle, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 238 Santa Ana Way, Duncan, SC 29334 Phone: 631-495-6084

Just Speechy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 Caperton Way, Duncan, SC 29334 Phone: 864-764-5863    Fax: 864-486-1686

Laura Ann Gray Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 Caperton Way, Duncan, SC 29334 Phone: 864-433-1181

News Archive

Pain medicine specialist receives award for new advances in oral fluid testing

This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.

Link between prenatal exposure to armed conflict and birth weight

A new study shows pregnant women exposed to armed conflict have a higher risk of giving birth to underweight babies, a result that could change the way aid is delivered to developing countries.

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Researchers from the Radboud UMC have conducted the first study globally to show that intensified antibiotic treatment can improve the prognosis of patients with tuberculous (TB) meningitis, the most severe form of TB which carries a mortality of up to 50%.

House Medicare 'doc fix' vote likely Thursday amidst disputes about cost, role in health reform

"On Thursday, the House is expected to pass a $210 billion measure — known as the 'doc fix' — that will adjust Medicare payment rates to avoid a 21 percent cut in January and continuing cuts in the years ahead," The New York Times reports, adding: "The House originally included the provision in its big health care bill. But it was dropped because its steep cost would have meant the bill would add to future federal deficits, violating one of President Obama's central requirements for the health legislation."

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that enrollment has commenced in its Phase 2b, open-label, safety and efficacy positron emission tomography imaging study of [18F]NAV4694 for detection of cerebral β-amyloid plaque in subjects diagnosed with Mild Cognitive Impairment.

Read more Medical News

› Verified 8 days ago